Companion Animal Vaccines Market

Future Market Insights suggests that within the companion animal vaccines landscape, the intersection of rising pet humanization trends and accelerating regulatory approval of recombinant and mRNA-based immunization platforms is redefining preventive veterinary care standards globally. Analysts identify the shift from traditional killed and modified-live vaccines to recombinant and next-generation therapeutic platforms as the central pivot point for the industry, effectively expanding the addressable market from core prophylactic shots to chronic disease management in pets.